Works matching IS 10870156 AND DT 2012 AND VI 30 AND IP 7

Results: 46

Incorporating biomarkers into clinical trial designs: points to consider.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 596, doi. 10.1038/nbt.2296

By:

Bradley, Edward

Publication type:

Article

Therapeutic targets in cancer cell metabolism and autophagy.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 671, doi. 10.1038/nbt.2285

By:

Cheong, Heesun;
Lu, Chao;
Lindsten, Tullia;
Thompson, Craig B

Publication type:

Article

UK's life sciences pitch.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 574, doi. 10.1038/nbt0712-574b

By:

Nasto, Barbara

Publication type:

Article

People.

Published in:: Nature Biotechnology, 2012, v. 30, n. 7, p. 724, doi. 10.1038/nbt.2306
Publication type:: Article

The Multiple Myeloma Research Foundation's evolving focus on drug R&D.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 600, doi. 10.1038/nbt.2297

By:

Giusti, Kathy

Publication type:

Article

The challenges posed by cancer heterogeneity.

Published in:

2012

By:

Bhatia, Sangeeta;
Frangioni, John V;
Hoffman, Robert M;
Iafrate, A John;
Polyak, Kornelia

Publication type:

Interview

Around the world in a month.

Published in:: Nature Biotechnology, 2012, v. 30, n. 7, p. 576, doi. 10.1038/nbt0712-576b
Publication type:: Article

Antibody specification beyond the target: claiming a later-generation therapeutic antibody by its target epitope.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 615, doi. 10.1038/nbt.2291

By:

Sandercock, Colin G;
Storz, Ulrich

Publication type:

Article

NCATS launches drug repurposing program.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 571, doi. 10.1038/nbt0712-571a

By:

Allison, Malorye

Publication type:

Article

ABSOLUTE cancer genomics.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 620, doi. 10.1038/nbt.2293

By:

Van Loo, Peter;
Campbell, Peter J

Publication type:

Article

Canada approves stem cell product.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 571, doi. 10.1038/nbt0712-571b

By:

Cyranoski, David

Publication type:

Article

Combinatorial drug therapy for cancer in the post-genomic era.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 679, doi. 10.1038/nbt.2284

By:

Al-Lazikani, Bissan;
Banerji, Udai;
Workman, Paul

Publication type:

Article

The sweet allure of XNA.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 624, doi. 10.1038/nbt.2298

By:

Steele, Fintan R;
Gold, Larry

Publication type:

Article

Oncolytic virotherapy.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 658, doi. 10.1038/nbt.2287

By:

Russell, Stephen J;
Peng, Kah-Whye;
Bell, John C

Publication type:

Article

Compressive genomics.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 627, doi. 10.1038/nbt.2241

By:

Loh, Po-Ru;
Baym, Michael;
Berger, Bonnie

Publication type:

Article

T-cell therapy at the threshold.

Published in:

2012

By:

June, Carl;
Rosenberg, Steven A;
Sadelain, Michel;
Weber, Jeffrey S

Publication type:

Interview

Keeping gut bugs from causing harm.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 626, doi. 10.1038/nbt.2312

By:

Jones, Susan

Publication type:

Article

Managing knowledge-intensive workers.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 721, doi. 10.1038/nbt.2299

By:

Massaro, Sebastiano

Publication type:

Article

Mending hearts in situ.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 626, doi. 10.1038/nbt.2314

By:

DeFrancesco, Laura

Publication type:

Article

California's CIRM courts industry.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 572, doi. 10.1038/nbt0712-572

By:

Rohn, Jennifer

Publication type:

Article

In this issue.

Published in:: Nature Biotechnology, 2012, v. 30, n. 7, p. vii, doi. 10.1038/nbt.2309
Publication type:: Article

Beyond counting tumor cells.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 578, doi. 10.1038/nbt.2295

By:

Kling, Jim

Publication type:

Article

Obama administration report underlines support for biotech.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 576, doi. 10.1038/nbt0712-576a

By:

Waltz, Emily

Publication type:

Article

CNVs from exome sequencing.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 626, doi. 10.1038/nbt.2311

By:

Mak, Craig

Publication type:

Article

Tandem fluorescent protein timers for in vivo analysis of protein dynamics.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 708, doi. 10.1038/nbt.2281

By:

Khmelinskii, Anton;
Keller, Philipp J;
Bartosik, Anna;
Meurer, Matthias;
Barry, Joseph D;
Mardin, Balca R;
Kaufmann, Andreas;
Trautmann, Susanne;
Wachsmuth, Malte;
Pereira, Gislene;
Huber, Wolfgang;
Schiebel, Elmar;
Knop, Michael

Publication type:

Article

Coalition aims to accelerate translation of cell therapies.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 573, doi. 10.1038/nbt0712-573

By:

Sinha, Gunjan

Publication type:

Article

Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 715, doi. 10.1038/nbt.2249

By:

Chambers, Stuart M;
Qi, Yuchen;
Mica, Yvonne;
Lee, Gabsang;
Zhang, Xin-Jun;
Niu, Lei;
Bilsland, James;
Cao, Lishuang;
Stevens, Edward;
Whiting, Paul;
Shi, Song-Hai;
Studer, Lorenz

Publication type:

Article

From single cells to deep phenotypes in cancer.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 639, doi. 10.1038/nbt.2283

By:

Bendall, Sean C;
Nolan, Garry P

Publication type:

Article

TAL effector RVD specificities and efficiencies.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 593, doi. 10.1038/nbt.2304

By:

Streubel, Jana;
Blücher, Christina;
Landgraf, Angelika;
Boch, Jens

Publication type:

Article

Recent patent applications in cancer biomarkers.

Published in:: Nature Biotechnology, 2012, v. 30, n. 7, p. 619, doi. 10.1038/nbt.2308
Publication type:: Article

Gene therapy matures in the clinic.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 588, doi. 10.1038/nbt.2290

By:

Seymour, Leonard W;
Thrasher, Adrian J

Publication type:

Article

First FDA-approved beta-amyloid diagnostic hits the market.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 575, doi. 10.1038/nbt0712-575

By:

Garber, Ken

Publication type:

Article

siRNAs on the edge.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 626, doi. 10.1038/nbt.2313

By:

Kreisberg, Jason

Publication type:

Article

A hybrid approach for the automated finishing of bacterial genomes.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 701, doi. 10.1038/nbt.2288

By:

Bashir, Ali;
Klammer, Aaron A;
Robins, William P;
Chin, Chen-Shan;
Webster, Dale;
Paxinos, Ellen;
Hsu, David;
Ashby, Meredith;
Wang, Susana;
Peluso, Paul;
Sebra, Robert;
Sorenson, Jon;
Bullard, James;
Yen, Jackie;
Valdovino, Marie;
Mollova, Emilia;
Luong, Khai;
Lin, Steven;
LaMay, Brianna;
Joshi, Amruta

Publication type:

Article

FDA approves pertuzumab.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 570, doi. 10.1038/nbt0712-570

By:

Sheridan, Cormac

Publication type:

Article

Recasting cancer trials.

Published in:: Nature Biotechnology, 2012, v. 30, n. 7, p. 567, doi. 10.1038/nbt.2315
Publication type:: Article

Plant genomics roundup.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 626, doi. 10.1038/nbt.2310

By:

Kreisberg, Jason

Publication type:

Article

Reading cancer's blueprint.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 581, doi. 10.1038/nbt.2292

By:

Eisenstein, Michael

Publication type:

Article

From academic solos to industrial symphonies.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 585, doi. 10.1038/nbt.2245

By:

Acton, Gwen;
Gómez-Yafal, Alicia;
Walsh, Emily

Publication type:

Article

Jazz beefs up with EUSA biologic.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 574, doi. 10.1038/nbt0712-574a

By:

Louët, Sabine

Publication type:

Article

Hybrid error correction and de novo assembly of single-molecule sequencing reads.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 693, doi. 10.1038/nbt.2280

By:

Koren, Sergey;
Schatz, Michael C;
Walenz, Brian P;
Martin, Jeffrey;
Howard, Jason T;
Ganapathy, Ganeshkumar;
Wang, Zhong;
Rasko, David A;
McCombie, W Richard;
Jarvis, Erich D;
Phillippy, Adam M

Publication type:

Article

The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 631, doi. 10.1038/nbt.2289

By:

Senter, Peter D;
Sievers, Eric L

Publication type:

Article

Swiss hope for phoenix from Merck Serono's ashes.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 569, doi. 10.1038/nbt0712-569

By:

Moran, Nuala

Publication type:

Article

New lysine methyltransferase drug targets in cancer.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 622, doi. 10.1038/nbt.2300

By:

Wagner, Tobias;
Jung, Manfred

Publication type:

Article

Debate over details of US biosimilar pathway continues to rage.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 577, doi. 10.1038/nbt0712-577

By:

Fox, Jeffrey L

Publication type:

Article

Modeling and predicting clinical efficacy for drugs targeting the tumor milieu.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 648, doi. 10.1038/nbt.2286

By:

Singh, Mallika;
Ferrara, Napoleone

Publication type:

Article